← Back to Search

Nasal Congestion Relief Device

Sonu Treatment Group for Nasal Congestion and Inflammation (SCORE Trial)

N/A
Waitlist Available
Led By Jacob Johnson, MD
Research Sponsored by Third Wave Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Present with symptoms of nasal congestion for 1 month or more prior to treatment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

SCORE Trial Summary

This trial tested a drug to treat severe stuffy nose and found it to be safe & effective.

Eligible Conditions
  • Nasal Congestion and Inflammation

SCORE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have experienced a prolonged bout of nasal congestion prior to commencing treatment.

SCORE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Effectiveness
Secondary outcome measures
Secondary Effectiveness

SCORE Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sonu Treatment GroupExperimental Treatment1 Intervention
Patients will receive acoustic resonance therapy for 15 minutes, twice a day, for two weeks using Sonu.
Group II: Sham Control GroupPlacebo Group1 Intervention
Patients will receive non-resonant acoustic energy for 15 minutes, twice a day, for two weeks using Sonu.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sonu
2022
N/A
~60

Find a Location

Who is running the clinical trial?

Third Wave TherapeuticsLead Sponsor
3 Previous Clinical Trials
325 Total Patients Enrolled
Jacob Johnson, MDPrincipal InvestigatorSan Francisco Otolaryngology Medical Group
4 Previous Clinical Trials
341 Total Patients Enrolled

Media Library

Sonu (Nasal Congestion Relief Device) Clinical Trial Eligibility Overview. Trial Name: NCT05821842 — N/A
Nasal Congestion and Inflammation Research Study Groups: Sham Control Group, Sonu Treatment Group
Nasal Congestion and Inflammation Clinical Trial 2023: Sonu Highlights & Side Effects. Trial Name: NCT05821842 — N/A
Sonu (Nasal Congestion Relief Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05821842 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project require additional volunteers?

"Affirmative. Clinicaltrials.gov reports that this trial, initially posted on March 23rd 2022, is actively searching for participants. 50 volunteers are required from 1 designated medical centre."

Answered by AI

How many participants are being treated as part of this research project?

"Affirmative. Records hosted on clinicaltrials.gov demonstrate that registration for this medical experiment, which was initially posted on March 23rd 2022, is in progress. Around 50 participants need to be enrolled from 1 centre."

Answered by AI

Who else is applying?

What site did they apply to?
San Francisco Otolaryngology Medical Group
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~17 spots leftby Mar 2025